cytosine arabinoside in a high dose of 3 g/m2 ( hd ara-c ) , alone or in combination with doxorubicin , has been advocated for the treatment of patients with acute non-lymphocytic leukaemia ( anll ) in relapse .
C0013089
doxorubicin
C0023467
acute non-lymphocytic leukaemia